Recent advances in immunostimulatory CpG oligonucleotides.

S Rothenfusser, E Tuma, M Wagner… - Current Opinion in …, 2003 - europepmc.org
The vertebrate immune system has evolved a mechanism to detect CpG motifs within
microbial DNA (CpG DNA). Synthetic oligonucleotides containing CpG motifs (CpG ODNs) …

Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates

D Verthelyi, DM Klinman - Clinical Immunology, 2003 - Elsevier
Oligodeoxynucleotides (ODN) containing CpG motifs mimic the ability of microbial DNA to
activate the innate immune system. The resultant response limits the early spread of …

CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials

Z Zhang, JCT Kuo, S Yao, C Zhang, H Khan, RJ Lee - Pharmaceutics, 2021 - mdpi.com
CpG oligodeoxynucleotides (CpG ODNs), the artificial versions of unmethylated CpG motifs
that were originally discovered in bacterial DNA, are demonstrated not only as potent …

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

Y Kojima, KQ Xin, T Ooki, K Hamajima, T Oikawa… - Vaccine, 2002 - Elsevier
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs trigger an
immune response characterized by the activation of B cells, NK cells and monocytes …

Synthetic oligonucleotides as modulators of inflammation

D Klinman, H Shirota, D Tross, T Sato… - Journal of Leucocyte …, 2008 - academic.oup.com
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs mimic the
immunostimulatory activity of bacterial DNA. CpG ODN directly stimulate human B cells and …

CpG DNA is an effective oral adjuvant to protein antigens in mice

MJ McCluskie, RD Weeratna, AM Krieg, HL Davis - Vaccine, 2000 - Elsevier
We have previously reported that synthetic oligodeoxynucleotides containing
immunostimulatory CpG motifs (CpG ODN) are potent adjuvants to protein administered by …

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

DM Klinman, H Xie, SF Little, D Currie, BE Ivins - Vaccine, 2004 - Elsevier
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune
adjuvants, improving the immune response elicited by co-administered vaccines. Combining …

From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA

AM Krieg - Antisense and Nucleic Acid Drug Development, 2001 - liebertpub.com
Several types of immune cells possess pattern recognition receptors (PRR) that can
distinguish prokaryotic DNA from vertebrate DNA by detecting unmethylated CpG …

An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems

PP Ho, P Fontoura, PJ Ruiz, L Steinman… - The Journal of …, 2003 - journals.aai.org
Bacterial DNA and immunostimulatory CpG oligodeoxynucleotides (ODNs) activate the
innate immune system to produce proinflammatory cytokines. Shown to be potent Th1-like …

CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.

B Jahrsdörfer, GJ Weiner - Current opinion in investigational drugs …, 2003 - europepmc.org
Synthetic oligodeoxynucleotides containing CG motifs (CpG ODNs) have potent
immunostimulatory properties, and have potential as immunotherapeutic agents in cancer …